Momelotinib, an aminopyrimidine derivative discovered by high-throughput enzyme and cell-based screening along with the optimization using structure-guided medicinal chemistry, is a potent and selective inhibitor of janus kinase 1 (JAK1), janus kinase 2 (JAK2) and tyrosine kinase 2 (TYK2).
The global Momelotinib market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Momelotinib is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Momelotinib is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Momelotinib include Abcam, Adooq Bioscience, APExBIO Technology, BioVision, Cayman Chemical, Toronto Research Chemicals, Santa Cruz Biotechnology, Enzo Biochem and Taiclone, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Momelotinib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Momelotinib.
The Momelotinib market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Momelotinib market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Momelotinib manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Abcam
Adooq Bioscience
APExBIO Technology
BioVision
Cayman Chemical
Toronto Research Chemicals
Santa Cruz Biotechnology
Enzo Biochem
Taiclone
Biorbyt
BOC Sciences
Aladdin
Segment by Type
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Segment by Application
Research
Medical
Production by Region
North America
Europe
China
Japan
Taiwan,China
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Momelotinib manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Momelotinib by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Momelotinib in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Momelotinib Market Overview
1.1 Product Definition
1.2 Momelotinib Segment by Type
1.2.1 Global Momelotinib Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Min Purity Less Than 98%
1.2.3 Min Purity 98%-99%
1.2.4 Min Purity More Than 99%
1.3 Momelotinib Segment by Application
1.3.1 Global Momelotinib Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Research
1.3.3 Medical
1.4 Global Market Growth Prospects
1.4.1 Global Momelotinib Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Momelotinib Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Momelotinib Production Estimates and Forecasts (2018-2029)
1.4.4 Global Momelotinib Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Momelotinib Production Market Share by Manufacturers (2018-2023)
2.2 Global Momelotinib Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Momelotinib, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Momelotinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Momelotinib Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Momelotinib, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Momelotinib, Product Offered and Application
2.8 Global Key Manufacturers of Momelotinib, Date of Enter into This Industry
2.9 Momelotinib Market Competitive Situation and Trends
2.9.1 Momelotinib Market Concentration Rate
2.9.2 Global 5 and 10 Largest Momelotinib Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Momelotinib Production by Region
3.1 Global Momelotinib Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Momelotinib Production Value by Region (2018-2029)
3.2.1 Global Momelotinib Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Momelotinib by Region (2024-2029)
3.3 Global Momelotinib Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Momelotinib Production by Region (2018-2029)
3.4.1 Global Momelotinib Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Momelotinib by Region (2024-2029)
3.5 Global Momelotinib Market Price Analysis by Region (2018-2023)
3.6 Global Momelotinib Production and Value, Year-over-Year Growth
3.6.1 North America Momelotinib Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Momelotinib Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Momelotinib Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Momelotinib Production Value Estimates and Forecasts (2018-2029)
3.6.5 Taiwan,China Momelotinib Production Value Estimates and Forecasts (2018-2029)
4 Momelotinib Consumption by Region
4.1 Global Momelotinib Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Momelotinib Consumption by Region (2018-2029)
4.2.1 Global Momelotinib Consumption by Region (2018-2023)
4.2.2 Global Momelotinib Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Momelotinib Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Momelotinib Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Momelotinib Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Momelotinib Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Momelotinib Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Momelotinib Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Momelotinib Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Momelotinib Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Momelotinib Production by Type (2018-2029)
5.1.1 Global Momelotinib Production by Type (2018-2023)
5.1.2 Global Momelotinib Production by Type (2024-2029)
5.1.3 Global Momelotinib Production Market Share by Type (2018-2029)
5.2 Global Momelotinib Production Value by Type (2018-2029)
5.2.1 Global Momelotinib Production Value by Type (2018-2023)
5.2.2 Global Momelotinib Production Value by Type (2024-2029)
5.2.3 Global Momelotinib Production Value Market Share by Type (2018-2029)
5.3 Global Momelotinib Price by Type (2018-2029)
6 Segment by Application
6.1 Global Momelotinib Production by Application (2018-2029)
6.1.1 Global Momelotinib Production by Application (2018-2023)
6.1.2 Global Momelotinib Production by Application (2024-2029)
6.1.3 Global Momelotinib Production Market Share by Application (2018-2029)
6.2 Global Momelotinib Production Value by Application (2018-2029)
6.2.1 Global Momelotinib Production Value by Application (2018-2023)
6.2.2 Global Momelotinib Production Value by Application (2024-2029)
6.2.3 Global Momelotinib Production Value Market Share by Application (2018-2029)
6.3 Global Momelotinib Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Abcam
7.1.1 Abcam Momelotinib Corporation Information
7.1.2 Abcam Momelotinib Product Portfolio
7.1.3 Abcam Momelotinib Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Abcam Main Business and Markets Served
7.1.5 Abcam Recent Developments/Updates
7.2 Adooq Bioscience
7.2.1 Adooq Bioscience Momelotinib Corporation Information
7.2.2 Adooq Bioscience Momelotinib Product Portfolio
7.2.3 Adooq Bioscience Momelotinib Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Adooq Bioscience Main Business and Markets Served
7.2.5 Adooq Bioscience Recent Developments/Updates
7.3 APExBIO Technology
7.3.1 APExBIO Technology Momelotinib Corporation Information
7.3.2 APExBIO Technology Momelotinib Product Portfolio
7.3.3 APExBIO Technology Momelotinib Production, Value, Price and Gross Margin (2018-2023)
7.3.4 APExBIO Technology Main Business and Markets Served
7.3.5 APExBIO Technology Recent Developments/Updates
7.4 BioVision
7.4.1 BioVision Momelotinib Corporation Information
7.4.2 BioVision Momelotinib Product Portfolio
7.4.3 BioVision Momelotinib Production, Value, Price and Gross Margin (2018-2023)
7.4.4 BioVision Main Business and Markets Served
7.4.5 BioVision Recent Developments/Updates
7.5 Cayman Chemical
7.5.1 Cayman Chemical Momelotinib Corporation Information
7.5.2 Cayman Chemical Momelotinib Product Portfolio
7.5.3 Cayman Chemical Momelotinib Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Cayman Chemical Main Business and Markets Served
7.5.5 Cayman Chemical Recent Developments/Updates
7.6 Toronto Research Chemicals
7.6.1 Toronto Research Chemicals Momelotinib Corporation Information
7.6.2 Toronto Research Chemicals Momelotinib Product Portfolio
7.6.3 Toronto Research Chemicals Momelotinib Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Toronto Research Chemicals Main Business and Markets Served
7.6.5 Toronto Research Chemicals Recent Developments/Updates
7.7 Santa Cruz Biotechnology
7.7.1 Santa Cruz Biotechnology Momelotinib Corporation Information
7.7.2 Santa Cruz Biotechnology Momelotinib Product Portfolio
7.7.3 Santa Cruz Biotechnology Momelotinib Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Santa Cruz Biotechnology Main Business and Markets Served
7.7.5 Santa Cruz Biotechnology Recent Developments/Updates
7.8 Enzo Biochem
7.8.1 Enzo Biochem Momelotinib Corporation Information
7.8.2 Enzo Biochem Momelotinib Product Portfolio
7.8.3 Enzo Biochem Momelotinib Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Enzo Biochem Main Business and Markets Served
7.7.5 Enzo Biochem Recent Developments/Updates
7.9 Taiclone
7.9.1 Taiclone Momelotinib Corporation Information
7.9.2 Taiclone Momelotinib Product Portfolio
7.9.3 Taiclone Momelotinib Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Taiclone Main Business and Markets Served
7.9.5 Taiclone Recent Developments/Updates
7.10 Biorbyt
7.10.1 Biorbyt Momelotinib Corporation Information
7.10.2 Biorbyt Momelotinib Product Portfolio
7.10.3 Biorbyt Momelotinib Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Biorbyt Main Business and Markets Served
7.10.5 Biorbyt Recent Developments/Updates
7.11 BOC Sciences
7.11.1 BOC Sciences Momelotinib Corporation Information
7.11.2 BOC Sciences Momelotinib Product Portfolio
7.11.3 BOC Sciences Momelotinib Production, Value, Price and Gross Margin (2018-2023)
7.11.4 BOC Sciences Main Business and Markets Served
7.11.5 BOC Sciences Recent Developments/Updates
7.12 Aladdin
7.12.1 Aladdin Momelotinib Corporation Information
7.12.2 Aladdin Momelotinib Product Portfolio
7.12.3 Aladdin Momelotinib Production, Value, Price and Gross Margin (2018-2023)
7.12.4 Aladdin Main Business and Markets Served
7.12.5 Aladdin Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Momelotinib Industry Chain Analysis
8.2 Momelotinib Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Momelotinib Production Mode & Process
8.4 Momelotinib Sales and Marketing
8.4.1 Momelotinib Sales Channels
8.4.2 Momelotinib Distributors
8.5 Momelotinib Customers
9 Momelotinib Market Dynamics
9.1 Momelotinib Industry Trends
9.2 Momelotinib Market Drivers
9.3 Momelotinib Market Challenges
9.4 Momelotinib Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Abcam
Adooq Bioscience
APExBIO Technology
BioVision
Cayman Chemical
Toronto Research Chemicals
Santa Cruz Biotechnology
Enzo Biochem
Taiclone
Biorbyt
BOC Sciences
Aladdin
*If Applicable.